You are here:
MEASUREMENT METHOD FOR VOLATILE METABOLIC BIOMARKERS IN EXHALED BREATH CONDENSATE
Citation:
PLEIL, J. D. MEASUREMENT METHOD FOR VOLATILE METABOLIC BIOMARKERS IN EXHALED BREATH CONDENSATE. Presented at International Association of Breath Research Workshop, Prague, CZECH REPUBLIC, September 04, 2006.
Impact/Purpose:
The objective of this task is to develop state-of-the-art methods for measuring xenobiotic compounds, to include the isolation of the analyte from the appropriate matrix (extraction), preconcentration (typically sorbent-based), and analysis via GC/MS and/or LC/MS. Once established, these methods will be applied in small scale pilot studies or demonstration projects. Particular emphasis will be placed on methods which are readily transferable to other laboratories, including those within the Human Exposure and Atmospheric Sciences Division (HEASD), the National Exposure Research Laboratory (NERL), other EPA Laboratories, Program Offices, Regions, and academic institutions.
Specific objectives of this task include the following:
1) Development of GC/MS and LC/MS methods for the measurement of key xenobiotic compounds and their metabolites (to include the pyrethroid pesticides, perfluorinated organic compounds, and the BFRs) in relevant environmental and biological matrices.
2) Development of efficient low cost methods for the extraction and clean up of these compounds collected from relevant matrices.
3) Determination of xenobiotic compound and metabolite concentrations in samples derived from laboratory and field monitoring studies to help assess exposures and evaluate associated risks.
Description:
EPA is developing biomarker methodology to interpret spot biological measurements and their linkage to previous environmental pollutants exposures for individuals. This work explores the use of a promising biological media, exhaled breath condensate (EBC), which contains trapped pulmonary aerosols and water soluble endogenous compounds. The desired outcome of this research is to identify patterns of molecules expressed in EBC that will indicate the level of cumulative exposure to groups of compounds from different sources experienced by a human subject.